Biosimilars, gene and cell therapies, and cancer drugs are filling the specialty pipeline. Here are some insights for each category to help you stay informed. This topic was the focus of a breakout...
Harold Carter, April 20, 22Read More
Each plan determines which formulary is best for its unique circumstances.
Katie Thompson, PharmD, August 24, 21Read More